Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Kronos Bio, Inc. (KRON) had Weighted-Average Shares Outstanding (Diluted) of 54.75M for the most recently reported fiscal year, ending 2021-12-31.
| Income Statement Financials | |
-- |
|
$-151.08M |
|
-- |
|
-- |
|
$151.40M |
|
$-151.40M |
|
$0.32M |
|
$-151.08M |
|
$-151.08M |
|
$-151.08M |
|
$-151.08M |
|
$-151.08M |
|
$-151.08M |
|
$-151.40M |
|
$-145.42M |
|
54.75M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
54.75M |
$-2.76 |
|
$-2.76 |
|
| Balance Sheet Financials | |
$347.55M |
|
$14.88M |
|
$43.92M |
|
$391.48M |
|
$13.63M |
|
-- |
|
$32.75M |
|
$46.38M |
|
$345.10M |
|
$345.10M |
|
$345.10M |
|
55.70M |
|
| Cash Flow Statement Financials | |
$-117.92M |
|
$63.72M |
|
$4.46M |
|
$250.04M |
|
$200.30M |
|
$-49.74M |
|
$26.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
25.51 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-122.18M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-43.78% |
|
-43.78% |
|
-38.59% |
|
-43.78% |
|
$6.20 |
|
$-2.23 |
|
$-2.15 |
|